← Leaderboards
Sophia Koo
Brigham And Women'S Hospital
$15,534,982
Attributed
$15,534,982
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,534,982 · 8
By mechanism
R01$8,514,920 · 2
U01$4,405,529 · 1
R21$1,929,933 · 4
K23$684,600 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Daniel R Kuritzkes$313,891,104
- Kenneth H Mayer$64,411,257
- Lynn Bry$10,918,358
- Lao-Tzu Allan-Blitz$387,618
- Lindsey Robert Baden$8,253,212
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionDiagnosisDiagnosticGas ChromatographyInfectionMetabolicDiagnostic ProcedureSpectrometryLaboratoriesDiagnostic TestsMycosesLungBaseCessation Of LifeSymptomsBreath TestsPressurePneumoniaMicrobialPoint Of CareGasesHospitalsDevicesAntibiotics
Grant awards (25)
A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States$1,190,094
U01 · FY2025 · TR · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnosis, Species Identification, and Antibiotic Resistance Profiling in Bacterial Pneumonia$753,224
R01 · FY2025 · AI · contact PI
A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States$1,208,710
U01 · FY2024 · TR · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnosis, Species Identification, and Antibiotic Resistance Profiling in Bacterial Pneumonia$816,494
R01 · FY2024 · AI · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia$1,106,914
R01 · FY2023 · AI · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnosis, Species Identification, and Antibiotic Resistance Profiling in Bacterial Pneumonia$1,001,442
R01 · FY2023 · AI · contact PI
A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States$982,580
U01 · FY2023 · TR · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia$1,125,660
R01 · FY2022 · AI · contact PI
A Novel Device for Rapid and Noninvasive Volatile Metabolite-based Screening and Diagnosis of Multiple Disease States$1,024,145
U01 · FY2022 · TR · contact PI
Breath Volatile Metabolites for the Diagnosis of Coccidioidomycosis$214,171
R21 · FY2022 · AI · contact PI
Breath Volatile Metabolites for the Diagnosis of Coccidioidomycosis$278,671
R21 · FY2021 · AI · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia$1,089,217
R01 · FY2020 · AI · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia$1,126,926
R01 · FY2019 · AI · contact PI
Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia$1,495,043
R01 · FY2018 · AI · contact PI
Rapid Breath-Based Diagnosis of Histoplasmosis$213,288
R21 · FY2018 · AI · contact PI
Aspergillus fumigatus Volatile Secondary Metabolite Dynamics for the Identification of Azole-resistant Aspergillosis$211,876
R21 · FY2018 · AI · contact PI
Rapid Breath-Based Diagnosis of Histoplasmosis$267,738
R21 · FY2017 · AI · contact PI
Aspergillus fumigatus Volatile Secondary Metabolite Dynamics for the Identification of Azole-resistant Aspergillosis$256,251
R21 · FY2017 · AI · contact PI
Volatile Metabolite-Based Detection of Clostridium difficile Infection$221,875
R21 · FY2016 · AI · contact PI
Breath Volatile Metabolites for the Diagnosis of Emerging Invasive Mold Infection$137,160
K23 · FY2016 · AI · contact PI
Volatile Metabolite-Based Detection of Clostridium difficile Infection$266,063
R21 · FY2015 · AI · contact PI
Breath Volatile Metabolites for the Diagnosis of Emerging Invasive Mold Infection$137,160
K23 · FY2015 · AI · contact PI
Breath Volatile Metabolites for the Diagnosis of Emerging Invasive Mold Infection$137,160
K23 · FY2014 · AI · contact PI
Breath Volatile Metabolites for the Diagnosis of Emerging Invasive Mold Infection$137,160
K23 · FY2013 · AI · contact PI
Breath Volatile Metabolites for the Diagnosis of Emerging Invasive Mold Infection$135,960
K23 · FY2012 · AI · contact PI